Pictet Asset Management’s BioNTech BNTX Stock Holding History

Pictet Asset Management’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$17.5M	Buy	185,803 +54,005	+41%	+$5.08M	0.02%	567
2026 Q1	$11.2M	Buy	131,798 +42,960	+48%	+$4.41M	0.01%	629
2025 Q4	$8.46M	Buy	88,838 +26,119	+42%	+$2.63M	0.01%	710
2025 Q3	$6.15M	Buy	62,719 +2,945	+5%	+$315K	0.01%	767
2025 Q2	$6.38M	Buy	59,774 +10,858	+22%	+$1.1M	0.01%	744
2025 Q1	$4.64M	Buy	48,916 +4,960	+11%	+$555K	0.01%	812
2024 Q4	$5.01M	Sell	43,956 -4,228	-9%	-$482K	0.01%	812
2024 Q3	$5.7M	Sell	48,184 -3,593	-7%	-$330K	0.01%	779
2024 Q2	$4.16M	Sell	51,777 -134,979	-72%	-$12.3M	﹤0.01%	810
2024 Q1	$17.2M	Buy	186,756 +56,764	+44%	+$5.44M	0.02%	521
2023 Q4	$13.7M	Sell	129,992 -50,116	-28%	-$5.05M	0.02%	568
2023 Q3	$19.6M	Buy	+180,108	New	+$19.9M	0.02%	463

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

GSK plc London $602M AUM

Pictet Asset Management's BNTX Position: Q2 2026 in Review

Pictet Asset Management increased its BioNTech (BNTX) stake by 41% in Q2 2026, buying an estimated $5.08M and bringing the position to 185,803 shares worth $17.5M. The position accounts for 0.02% of the portfolio, ranked #567.

Pictet Asset Management first reported a position in BNTX in Q3 2023 and has held it in 12 quarters since. The position peaked at $19.6M in Q3 2023. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

Pictet Asset Management held 185,803 shares of BioNTech worth $17.5M as of Q2 2026.
Pictet Asset Management bought 54,005 BioNTech shares in Q2 2026, an estimated $5.08M.
BioNTech made up 0.02% of Pictet Asset Management's portfolio in Q2 2026, its #567 holding.
Pictet Asset Management first reported a position in BioNTech in Q3 2023 and has held it in 12 quarters since.
Pictet Asset Management's BioNTech position peaked at $19.6M in Q3 2023.
282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.